LFCR LIFECORE BIOMEDICAL, INC. DEcompanySEC Filings & Insider Trading Activity 2026
Latest LIFECORE BIOMEDICAL, INC. DE (LFCR) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on August 7, 2025, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on March 16, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for LIFECORE BIOMEDICAL, INC. DE (LFCR) (SEC CIK 1005286), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Investor presentation published March 16, 2026 on LFCR's website — full details in Exhibit 99.2
- • Reg FD disclosure ensures simultaneous public access; content may include guidance, strategy, or financial updates material to valuation
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full transition period results ending Dec 31, 2025 now reported by Lifecore Biomedical (LFCR)
- • Press release (Exhibit 99.1) contains full financial details — primary source for revenue, margins, and earnings figures
Item 5.08: Shareholder Director Nominations
- • Fiscal year changed from last-Sunday-of-May end to calendar year (Dec 31), effective for transition period May 26–Dec 31, 2025
- • 2026 Annual Meeting set for June 4, 2026 — shifted >30 days from prior year's Oct 29, 2025 meeting date
Recent 8-K FilingsCurrent Reports
AI-powered analysis of LIFECORE BIOMEDICAL, INC. DE (LFCR) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 16, 2026 | — | Analysis | — |
8-K | Mar 5, 2026 | — | Analysis | — |
8-K | Jan 16, 2026 | — | — | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | — | |
10-K | Aug 7, 2025 | May 25, 2025 | — | |
10-Q | Apr 3, 2025 | Feb 23, 2025 | — | |
10-Q | Jan 2, 2025 | Nov 24, 2024 | — | |
10-Q | Oct 4, 2024 | Aug 25, 2024 | — | |
10-K | Aug 26, 2024 | May 26, 2024 | — | |
10-Q | Aug 9, 2024 | Nov 26, 2023 | — | |
10-Q | Aug 9, 2024 | Aug 27, 2023 | — | |
10-Q | Aug 9, 2024 | Feb 25, 2024 | — | |
10-K | Mar 20, 2024 | May 28, 2023 | — | |
10-Q | Jun 2, 2023 | Feb 26, 2023 | — | |
10-Q | Mar 16, 2023 | Nov 27, 2022 | — | |
10-Q | Oct 7, 2022 | Aug 28, 2022 | — | |
10-K | Sep 14, 2022 | May 29, 2022 | — | |
10-Q | Apr 7, 2022 | Feb 27, 2022 | — | |
10-Q | Jan 7, 2022 | Nov 28, 2021 | — | |
10-Q | Oct 5, 2021 | Aug 29, 2021 | — | |
10-K | Jul 29, 2021 | May 30, 2021 | — | |
10-Q | Apr 8, 2021 | Feb 28, 2021 | — | |
10-Q | Jan 7, 2021 | Nov 29, 2020 | — | |
10-Q | Oct 7, 2020 | Aug 30, 2020 | — | |
10-K | Aug 14, 2020 | May 31, 2020 | — |
Frequently Asked Questions
What are the latest LFCR SEC filings in 2026?
LIFECORE BIOMEDICAL, INC. DE (LFCR) has filed a 10-K annual report on August 7, 2025, a 10-Q quarterly report on November 6, 2025, an 8-K current report on March 16, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did LFCR file its most recent 10-K annual report?
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed its most recent 10-K annual report on August 7, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view LFCR 10-Q quarterly reports?
LIFECORE BIOMEDICAL, INC. DE (LFCR)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every LFCR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has LFCR filed recently?
LIFECORE BIOMEDICAL, INC. DE (LFCR)'s most recent 8-K was filed on March 16, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find LFCR insider trading activity (Form 4)?
SignalX aggregates every LFCR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does LFCR file with the SEC?
LIFECORE BIOMEDICAL, INC. DE (LFCR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new LFCR filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for LIFECORE BIOMEDICAL, INC. DE (LFCR).
What is LFCR's SEC CIK number?
LIFECORE BIOMEDICAL, INC. DE (LFCR)'s SEC CIK (Central Index Key) number is 1005286. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1005286 to look up all LFCR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find LFCR return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from LIFECORE BIOMEDICAL, INC. DE (LFCR) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of LIFECORE BIOMEDICAL, INC. DE SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 59+ filings.